Antibodies Having Specificity for btn2 and Uses Thereof

text
May 26, 2022

Inventors

Etienne Foucher, Carla Cano, Kieu Suong LE, Christine Pasero, Daniel Olive

Assignees

  1. Aix Marseille Universite
  2. Centre National de la Recherche Scientifique CNRS
  3. Institut National de la Sante et de la Recherche Medicale INSERM
  4. Institut Jean Paoli and Irene Calmettes
  5. Imcheck Therapeutics SAS

Abstract

The present invention relates to antibodies having specificity for BTN2A and uses thereof, in particular for the treatment of cancer.

CovalX Technology Used

Epitope Mapping
XL-MS

Contact our Scientific Team to Start the Conversation

Request A Call
Source
https://patents.google.com/patent/US20220162305A1/en
Back
Categories : Patents, Epitope Mapping
text
PREVIOUS : Plasma and Serum Exosome Markers Analyzed by Matrix-Assisted Laser Desorption/ionization Time-of-flight Mass Spectrometry Coupled with Electron Multiplier
NEXT : Hyaluronic acid detection and relative quantification by mass spectrometry imaging in human skin tissues
text